invivo car-t
invivo car-t: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: PRECISION BIOSCIENCES INC (DTIL)
Development Pipeline (1)
| Company | Phase |
|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | Phase 1 |
Clinical Trials (1)
In Vivo Prepared PICX Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma
Frequently asked questions
Who is developing invivo car-t?
invivo car-t is being developed by PRECISION BIOSCIENCES INC.
How many clinical trials involve invivo car-t?
BioSniper tracks 1 clinical trial involving invivo car-t.
Analyze PRECISION BIOSCIENCES INC & invivo car-t with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company